These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 25391265

  • 1. Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer.
    Nakagawa M, Inokuchi M, Takagi Y, Kato K, Sugita H, Otsuki S, Kojima K, Uetake H, Sugihara K.
    Ann Surg Oncol; 2015 Jul; 22(7):2329-35. PubMed ID: 25391265
    [Abstract] [Full Text] [Related]

  • 2. TPX2 expression is associated with poor survival in gastric cancer.
    Tomii C, Inokuchi M, Takagi Y, Ishikawa T, Otsuki S, Uetake H, Kojima K, Kawano T.
    World J Surg Oncol; 2017 Jan 09; 15(1):14. PubMed ID: 28069036
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D, Bilici A, Yavuzer D, Kefeli U, Tan A, Ercelep O, Mert A, Yuksel S, Ozcelik M, Isik D, Surmeli H, Odabasi H, Aliustaoglu M.
    Clin Transl Oncol; 2015 Aug 09; 17(8):604-11. PubMed ID: 25786367
    [Abstract] [Full Text] [Related]

  • 4. Expression of EphA1 in gastric carcinomas is associated with metastasis and survival.
    Wang J, Dong Y, Wang X, Ma H, Sheng Z, Li G, Lu G, Sugimura H, Zhou X.
    Oncol Rep; 2010 Dec 09; 24(6):1577-84. PubMed ID: 21042754
    [Abstract] [Full Text] [Related]

  • 5. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
    Zhang Y, Sun Y, Li Y, Fang Z, Wang R, Pan Y, Hu H, Luo X, Ye T, Li H, Wang L, Chen H, Ji H.
    Ann Surg Oncol; 2013 Dec 09; 20 Suppl 3():S577-82. PubMed ID: 23775406
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of PAK4 expression in gastric cancer.
    Kobayashi K, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Sato Y, Yanaka Y, Higuchi K, Aburatani T, Tomii C, Uetake H, Kojima K, Kawano T.
    J Clin Pathol; 2016 Jul 09; 69(7):580-5. PubMed ID: 26614788
    [Abstract] [Full Text] [Related]

  • 7. Prognostic Significance of High EphA1-4 Expression Levels in Locally Advanced Gastric Cancer.
    Inokuchi M, Nakagawa M, Baogok N, Takagi Y, Tanioka T, Gokita K, Okuno K, Kojima K.
    Anticancer Res; 2018 Mar 09; 38(3):1685-1693. PubMed ID: 29491103
    [Abstract] [Full Text] [Related]

  • 8. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
    Yu S, Li G, Wang Z, Wang Z, Chen C, Cai S, He Y.
    Tumour Biol; 2016 Nov 09; 37(11):15007-15017. PubMed ID: 27655288
    [Abstract] [Full Text] [Related]

  • 9. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.
    J Clin Pathol; 2015 Oct 09; 68(10):795-801. PubMed ID: 26043748
    [Abstract] [Full Text] [Related]

  • 10. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
    Inokuchi M, Murase H, Otsuki S, Kawano T, Kojima K.
    World J Surg Oncol; 2017 Jan 05; 15(1):2. PubMed ID: 28056982
    [Abstract] [Full Text] [Related]

  • 11. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
    Ozawa T, Kazama S, Akiyoshi T, Murono K, Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kanazawa T, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Morikawa T, Fukayama M, Watanabe T.
    Ann Surg Oncol; 2014 Aug 05; 21(8):2650-8. PubMed ID: 24728738
    [Abstract] [Full Text] [Related]

  • 12. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.
    An JY, Kim KM, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S.
    Int J Cancer; 2010 Jun 15; 126(12):2904-13. PubMed ID: 19739122
    [Abstract] [Full Text] [Related]

  • 13. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
    Lu G, Zhou L, Zhang X, Zhu B, Wu S, Song W, Gong X, Wang D, Tao Y.
    World J Surg Oncol; 2016 Oct 28; 14(1):276. PubMed ID: 27793161
    [Abstract] [Full Text] [Related]

  • 14. High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
    Lin C, Zhang Z, Xu Y, Wang R, Chen S, Gao J, Wang D, Huang Q, Tu X, Wang L.
    Am J Clin Pathol; 2016 Sep 28; 146(3):278-88. PubMed ID: 27543975
    [Abstract] [Full Text] [Related]

  • 15. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
    Sun X, Sun Z, Zhu Z, Li C, Zhang J, Xu H, Sun M.
    Tumour Biol; 2015 Sep 28; 36(10):7521-30. PubMed ID: 25913622
    [Abstract] [Full Text] [Related]

  • 16. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
    Nagatsuma AK, Aizawa M, Kuwata T, Doi T, Ohtsu A, Fujii H, Ochiai A.
    Gastric Cancer; 2015 Apr 28; 18(2):227-38. PubMed ID: 24626858
    [Abstract] [Full Text] [Related]

  • 17. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
    Lee CM, Cho JM, Jang YJ, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, Kim JH.
    Ann Surg Oncol; 2015 Mar 28; 22(3):765-71. PubMed ID: 25201506
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
    Ertao Z, Jianhui C, Kang W, Zhijun Y, Hui W, Chuangqi C, Changjiang Q, Sile C, Yulong H, Shirong C.
    Tumour Biol; 2016 Oct 28; 37(10):13679-13685. PubMed ID: 27473085
    [Abstract] [Full Text] [Related]

  • 19. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ.
    Ann Surg Oncol; 2010 Jan 28; 17(1):89-97. PubMed ID: 19820999
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J, Kanomata N, Yamashita T, Shimo T, Mizutoh A, Moriya T, Sonoo H.
    Breast Cancer; 2015 May 28; 22(3):292-9. PubMed ID: 23749689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.